Eng
8. WHY DO WE CERTIFY ISO STANDARDS AT INGALFARMA?
At Ingalfarma, we have certified the ISO 9001: 2015 standard for quality and ISO 13485: 2016 for quality in medical devices. What does this mean and how does it translate into our products? There are numerous definitions, but in simple words, quality is the set of properties and characteristics of a product or service that … Leer más
3. DENTOXOL® ENTERS GES PROGRAMME
Ingalfarma announces that its product Dentoxol® has been incorporated into the GES programme of one of the most important health insurance companies in the country, in prophylaxis of oral mucositis in lung cancer.
4. PUBLICATION OF ESDOM STUDY
Ingalfarma announces the recent publication of its Multicenter, Phase 2, Clinical Trial, for the Evaluation of the Efficacy and Safety of Dentoxol® in the prevention of oral mucositis in head and neck cancer patients in the international journal Supportive Care in Cancer. «It has been very gratifying and enriching to have achieved this milestone for … Leer más
5. DIARIO FINANCIERO HIGHLIGHTS THE USE OF DENTOXOL® IN POST-VENTILATED PATIENTS
Ingalfarma performs product tests on COVID-19 patients connected to mechanical ventilators, to treat oral lesions caused by connection to respirators, helping to lessen these adverse effects and help to recover, as soon as possible, their normal diet. «At Ingalfarma, we always want to contribute from the medical perspective of comprehensive management, in the recovery of … Leer más
6. GRANT OF CORFO FUNDS FOR INTERNATIONALIZATION
To support its 2020-2021 internationalization plan, Ingalfarma has been awarded a new CORFO fund called Consolidation and Expansion. “In order to enhance Chile’s entrepreneurial ecosystem, CORFO’s support of the last 10 years has been essential. This line of financing, in our opinion, goes in the right direction to continue accompanying StartUps beyond the seed stage, … Leer más
7. ISO 9001 CERTIFICATION
During the month of March 2020, Ingalfarma underwent the follow-up audit of the ISO 9001 certification, initially obtained in March 2019. The results of this audit carried out by the international certifying house AENOR, were satisfactory, allowing us to continue with our quality management system.